Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

When companies post strong earnings, the stock generally performs well, just like Pfizer Inc.'s ( NYSE:PFE ) stock ...

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...

Global pharmaceutical company Pfizer (NYSE:PFE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling ...

Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells ...

The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of $14.1 billion and $0.68, respectively.

Pfizer CEO says tariffs are discouraging the company from investing in the US. Pfizer's full-year guidance does not factor in ...

A listing on the New York Stock Exchange will follow shortly, according to the pharma group. It also confirmed that Pfizer – which holds a 32% stake in the current consumer health joint venture ...

Pfizer still has another obesity pill in development, PF-07976016, which is currently in a Phase IIa trial. Pfizer has terminated the development of its oral obesity candidate danuglipron after a ...

Get insights into Pfizer's Q1 earnings, including challenges like patent expiries & pricing controls, and discover why analysts remain cautious yet hopeful.